Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2966499 | 0.80 | DCUN1D1 (0.31) | — | |
| SCHEMBL2962328 | 0.75 | ATM (0.32) | ATM | |
| SCHEMBL3064332 | 0.75 | DCUN1D1 (0.40) | — | |
| SCHEMBL216981 | 0.73 | ACHE (0.39) | — | |
| SCHEMBL12694125 | 0.71 | CYP2A6 (0.45) | ATM | |
| SCHEMBL27469812 | 0.71 | ACHE (0.38) | — | |
| SCHEMBL2971154 | 0.71 | — | — | |
| SCHEMBL12523293 | 0.70 | BRD4 (0.41) | ATM | |
| SCHEMBL218438 | 0.70 | TSHR (0.34) | — | |
| SCHEMBL2959272 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1638919-B1 | SPHINGOLIPIDS POLYALKYLAMINES CONJUGATES | BIOLAB LTD (IL) | 2012-09-26 | — | — | EP | claimed |
| US-8242089-B2 | Sphingolipids polyalkylamine conjugates for use in transfection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2012-08-14 | — | — | US | claimed |
| US-7771711-B2 | Sphingolipids' polyalkylamines conjugates | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2010-08-10 | — | — | US | claimed |
| US-20080112917-A1 | Sphingolipids' Polyalkylamines Conjugates | BIOLAB LTD. (IL) | 2008-05-15 | — | — | US | claimed |
| US-20070212403-A1 | Method for Selecting Cationic or Anionic Liposomes for Treatment of a Mucosa Membrane, and Kit Comprising the Same | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2007-09-13 | — | — | US | claimed |
| JP-2006527763-A | — | — | 2006-12-07 | — | — | JP | claimed |
| US-20060252718-A1 | Sphingolipids polyalkylamine conjugates for use in transfection | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERISTY OF JERUSALEM (IL) | 2006-11-09 | — | — | US | claimed |
| EP-1694298-A2 | METHOD FOR SELECTING CATIONIC OR ANIONIC LIPOSOMES FOR TREATMENT OF A MUCOSA MEMBRANE, AND KIT COMPRISING THE SAME | Yissum Research Development Company, of The Hebrew University of Jerusalem (IL) | 2006-08-30 | — | — | EP | claimed |
| EP-1638919-A1 | SPHINGOLIPIDS POLYALKYLAMINES CONJUGATES | Biolab Ltd. (IL) | 2006-03-29 | — | — | EP | claimed |
| WO-2005041932-A2 | METHOD FOR SELECTING CATIONIC OR ANIONIC LIPOSOMES FOR TREATMENT OF A MUCOSA MEMBRANE, AND KIT COMPRISING THE SAME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2005-05-12 | — | — | WO | claimed |
| WO-2004110980-A1 | SPHINGOLIPIDS' POLYALKYLAMINES CONJUGATES | BIOLAB LTD. (IL) | 2004-12-23 | — | — | WO | claimed |
| EP-1638610-B1 | SPHINGOID POLYALKYLAMINE CONJUGATES FOR VACCINATION | YISSUM RES DEV CO (IL) | 2015-03-18 | — | — | EP | disclosed |
| EP-1638611-B1 | SPHINGOLIPIDS POLYALKYLAMINE CONJUGATES FOR USE IN TRANSFECTION | YISSUM RES DEV CO (IL) | 2012-10-03 | — | — | EP | disclosed |
| EP-1638919-B1 | SPHINGOLIPIDS POLYALKYLAMINES CONJUGATES | BIOLAB LTD (IL) | 2012-09-26 | — | — | EP | disclosed |
| US-7906122-B2 | Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERSUSALEM (IL) | 2011-03-15 | — | — | US | disclosed |
| EP-1638611-A1 | SPHINGOLIPIDS POLYALKYLAMINE CONJUGATES FOR USE IN TRANSFECTION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2006-03-29 | — | — | EP | disclosed |
| WO-2005041932-A2 | METHOD FOR SELECTING CATIONIC OR ANIONIC LIPOSOMES FOR TREATMENT OF A MUCOSA MEMBRANE, AND KIT COMPRISING THE SAME | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2005-05-12 | — | — | WO | disclosed |
| WO-2004110980-A1 | SPHINGOLIPIDS' POLYALKYLAMINES CONJUGATES | BIOLAB LTD. (IL) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004110496-A1 | SPHINGOID POLYALKYLAMINE CONJUGATES FOR VACCINATION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-12-23 | — | — | WO | disclosed |
| WO-2004110499-A1 | SPHINGOLIPIDS POLYALKYLAMINE CONJUGATES FOR USE IN TRANSFECTION | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 2004-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080112917-A1 | Sphingolipids' Polyalkylamines Conjugates | SGMS1, SGMS2, SPTLC1 | ATM 4847/4885 |
| US-20060252718-A1 | Sphingolipids polyalkylamine conjugates for use in transfection | SGMS1, SGMS2, CERT1 | ATM 4872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.